candesartan has been researched along with thymidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Backer, J; Fierensa, FL; Roggeman, C; Thekkumkara, TJ; Vanderheyden, PM; Vauquelin, G | 1 |
| Caballero-George, C; Gupta, MP; Pieters, L; Solis, PN; Vanderheyden, PM; Vauquelin, G; Vlietinck, A | 1 |
2 other study(ies) available for candesartan and thymidine
| Article | Year |
|---|---|
Tight binding of the angiotensin AT(1) receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biological Transport; Biphenyl Compounds; Cell Membrane; CHO Cells; Cricetinae; Endocytosis; Gene Deletion; Inositol Phosphates; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Thymidine; Tritium | 2001 |
In vitro effect of sanguinarine alkaloid on binding of [3H]candesartan to the human angiotensin AT1 receptor.
Topics: Alkaloids; Animals; Benzimidazoles; Benzophenanthridines; Binding, Competitive; Biphenyl Compounds; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Isoquinolines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Thymidine; Transfection; Tritium | 2003 |